← Leaderboards
S. Hossein Fatemi
University Of Minnesota Twin Cities
$5,520,257
Attributed
$5,520,257
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2005–14$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$5,520,257 · 5
By mechanism
R01$5,283,529 · 4
P50$236,728 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Minnesota Twin Cities
Same institution · by research overlap
- Kelly P Cosgrove$17,821,268
- Klearchos K Papas$6,678,370
- Michael Kotlyar$2,033,205
- Partha Pratim Mitra$39,358,147
Others in their field
Top investigators on “Affect”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$287,585,588
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$209,385,844
- David Heimbrook · Leidos Biomedical Research, Inc.$168,138,264
- Daniel R Kuritzkes · Brigham And Women'S Hospital$151,687,019
Research focus
AffectSchizophreniaBiochemicalBrainHippocampus (Brain)GenesProteinsSignal TransductionNeurodevelopmental DisorderCerebellumPrevalenceLaboratoriesExpectationGene FamilyCognitionAreaBrain RegionPathologyApolipoprotein E Receptor 2Gaba ReceptorFunctional DisorderGamma-Aminobutyric AcidAutopsyGlutamate Decarboxylase
Grant awards (22)
GABAergic and Reelin Deficits in Schizophrenia$336,353
R01 · FY2014 · MH · contact PI
GABAergic and Reelin Deficits in Schizophrenia$322,898
R01 · FY2013 · MH · contact PI
GABAergic and Reelin Deficits in Schizophrenia$336,353
R01 · FY2012 · MH · contact PI
GABAergic and Reelin Deficits in Schizophrenia$336,353
R01 · FY2011 · MH · contact PI
GABAergic Dysfunction in Autism$278,486
R01 · FY2011 · HD · contact PI
Varenicline and Smoking Cessation in Schizophrenia$424,378
R01 · FY2010 · DA · contact PI
GABAergic and Reelin Deficits in Schizophrenia$339,750
R01 · FY2010 · MH · contact PI
GABAergic Dysfunction in Autism$290,090
R01 · FY2010 · HD · contact PI
Varenicline and Smoking Cessation in Schizophrenia$416,453
R01 · FY2009 · DA · contact PI
GABAergic Dysfunction in Autism$294,344
R01 · FY2009 · HD · contact PI
Prenatal Virally Induced Brain Disorder in Mouse$87,714
R01 · FY2009 · HD · contact PI
GABAergic Dysfunction in Autism$63,950
R01 · FY2009 · HD · contact PI
GABAergic Dysfunction in Autism$294,333
R01 · FY2008 · HD · contact PI
Prenatal Virally Induced Brain Disorder in Mouse$277,513
R01 · FY2008 · HD · contact PI
GABAergic Dysfunction in Autism$312,703
R01 · FY2007 · HD · contact PI
Prenatal Virally Induced Brain Disorder in Mouse$276,693
R01 · FY2007 · HD · contact PI
Prenatal Virally Induced Brain Disorder in Mouse$277,484
R01 · FY2006 · HD · contact PI
Prenatal Virally Induced Brain Disorder in Mouse$317,681
R01 · FY2005 · HD
PILOT STUDY--BUPROPION HCL AND PLACEBO TREATMENT OF SMOKING IN SCHIZOPHRENICS$0
P50 · FY2002 · DA
PILOT STUDY--BUPROPION HCL AND PLACEBO TREATMENT OF SMOKING IN SCHIZOPHRENICS$0
P50 · FY2002 · DA
PILOT STUDY--BUPROPION HCL AND PLACEBO TREATMENT OF SMOKING IN SCHIZOPHRENICS$0
P50 · FY2001 · DA
PILOT STUDY--BUPROPION HCL AND PLACEBO TREATMENT OF SMOKING IN SCHIZOPHRENICS$236,728
P50 · FY2000 · DA